Validation of the Gendolcat Score for the Prognosis of Chronic Postoperative Pain in Cesarean Section
Unknown statusNCT05739747
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Chronic post-surgical pain is a problem that has historically been underestimated. Over the last few years there has been a search for strategies to both predict and prevent its occurrence in patients undergoing surgery. The Gendolcat index is the only predictive model that uses only objective pre-surgical variables to assess the risk of suffering chronic post-surgical pain. However, it is only validated for the following surgeries: thoracotomy, hysterectomy and open inguinal hernia. Our aim is to test whether the Gendolcat model is also valid for cesarean section.
Study details
- Official title
- Validation of the Gendolcat Score for the Prognosis of Chronic Postoperative Pain in Cesarean Section.
- Conditions
- Chronic Post Surgical Pain
- Cesarean Section Complications
- Chronic Pain
- Interventions
- Other: Questionnaire
- Other: Questionnaire
- Other: Questionnaire
- Other: Questionnaire via telephone call
- Other: Physical examination
- Sponsor
- Consorci Sanitari de Terrassa
- Start date
- 2023-04-01
- Primary completion
- 2024-02
- Sex
- Female
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Spain
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients who underwent elective caesarean section. * Patients who have previously signed the informed consent form. Exclusion Criteria * Urgent cesarean section. * Patients with severe psychiatric pathology. * Patients who require a different surgical approach than usual. * Patients who refuse to take part in the study and/or to sign the informed consent form. informed consent. \- Patients with a high language barrier.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05739747